The DOI matches its Crossref record.
Natural Product Drug Discovery and Development: New Perspectives on International Collaboration
Abstract
Until recently, the prevailing attitude in developed nations regarded the world's genetic resources, which are mainly concentrated in the developing world, as a common resource of humankind, to be exploited freely irrespective of national origin. With the devastation being wreaked in the tropical rainforests and the resurgence in interest in recent years in the discovery of novel drugs from natural sources, particularly plants and marine organisms, the international scientific community has realized that the conservation of these global genetic resources and the indigenous knowledge associated with their use are of primary importance if their potential is to be fully explored. With this realization has come a recognition that these goals must be achieved through collaboration with, and fair and equitable compensation of, the scientists and communities of the genetically rich source countries. The signing of the United Nations Convention on Biological Diversity by nearly all of the World's nations has emphasized the need for the implementation of such policies. In this review, the articles of the Convention of relevance to the activities and practices of the natural products scientific community are briefly discussed. This discussion is followed by a summary of policies for international collaboration and compensation being implemented by several developed country organizations, and the perspectives on the current developments given by representatives of some of the source countries located in the regions of greatest biodiversity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The value of plants used in traditional medicine for drug discovery.
Fabricant, D. S., & Farnsworth, N. R. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s169 · Cited by 2,038
Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture
Bussmann, R. W., & Sharon, D. (2006) · Journal of Ethnobiology and Ethnomedicine · doi:10.1186/1746-4269-2-47 · Cited by 1,120
Advancing a Political Ecology of Global Environmental Discourses
Adger, W. N., Benjaminsen, T. A., Brown, K., & Svarstad, H. (2001) · Development and Change · doi:10.1111/1467-7660.00222 · Cited by 782
Strategies for discovering drugs from previously unexplored natural products
Harvey, A. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01511-7 · Cited by 542
Natural Product Drug Discovery in the Next Millennium
Cragg, G., & Newman, D. (2001) · Pharmaceutical Biology · doi:10.1076/phbi.39.7.8.5868 · Cited by 448
Self-citationBussmann, R. W., Malca-García, G., Glenn, A., Sharon, D., Chait, G., Díaz, D., Pourmand, K., Jonat, B., Somogy, S., Guardado, G., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.048 · Cited by 425
Discursive biases of the environmental research framework DPSIR
Svarstad, H., Petersen, L. K., Rothman, D., Siepel, H., & Wätzold, F. (2008) · Land Use Policy · doi:10.1016/j.landusepol.2007.03.005 · Cited by 388
Compounds from Wild Mushrooms with Antitumor Potential
C.F.R. Ferreira, I., A. Vaz, J., Vasconcelos, M. H., & Martins, A. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611009050424 · Cited by 334
Natural products as targeted modulators of the nuclear factor-κ B pathway
Bremner, P., & Heinrich, M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778637 · Cited by 312
E., O. F. (2003) · African Journal of Biotechnology · doi:10.5897/ajb2003.000-1122 · Cited by 297
Pharmacognosy in the New Millennium: Leadfinding and Biotechnology
Verpoorte, R. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773931 · Cited by 274
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
De Smet, P. A. G. M. (1997) · Drugs · doi:10.2165/00003495-199754060-00003 · Cited by 268
Patented antiinflammatory plant drug development from traditional medicine
Darshan, S., & Doreswamy, R. (2004) · Phytotherapy Research · doi:10.1002/ptr.1475 · Cited by 168
Metadata
- Authors
- Baker, J. T., Borris, R. P., Carté, B., Cordell, G. A., Soejarto, D. D., Cragg, G. M., Gupta, M. P., Iwu, M. M., Madulid, D. R., & Tyler, V. E.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-09
- Volume
- 58
- Issue
- 9
- Pages
- 1325-1357
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W1991672646
- Cited by
- 349
- References
- 0
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.